Delivery Order SPE2DB20D9129-SPE2DB22FC5MC

Award Date 1/3/22

Potential Completion Date 1/4/22

Potential Value $0.01

Federal Agency

Defense Logistics Agency

Awardee

DMS Pharmaceutical Group Inc. PX72BSBQTKJ3

Ultimate Awardee

Not listed

NAICS Category

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Park Ridge, IL 60068, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

DMS Pharmaceutical Group Inc. was awarded a delivery order against an unspecified government-wide acquisition contract by the Defense Logistics Agency for the provision of 400 mg/250 ml bags of moxifloxacin intravenous solution. The delivery order has a firm fixed price of zero dollars and requires completion by January 4, 2022. To be performed in Park Ridge, Illinois, the order is for moxifloxacin, an antibiotic, to support the medical supply needs of the Defense Logistics Agency. No set-aside provisions or subcontractors are associated with this delivery order for pharmaceutical products.

Generated 1/3/24, 5:59 AM